Predictive value of DNA methylation patterns in AML patients treated with an azacytidine containing induction regimen
Abstract Background Acute myeloid leukemia (AML) is a heterogeneous disease with a poor prognosis. Dysregulation of the epigenetic machinery is a significant contributor to disease development. Some AML patients benefit from treatment with hypomethylating agents (HMAs), but no predictive biomarkers...
Guardat en:
| Autors principals: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2023-10-01
|
| Col·lecció: | Clinical Epigenetics |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s13148-023-01580-z |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|